Congenital Analgesia: A Rare and Dangerous Genetic Condition
- Ameisha Khan
- Jul 13
- 2 min read
What is Congenital analgesia?
Congenital analgesia, also known as congenital insensitivity to pain (CIP), is a rare genetic condition in which an individual can not feel or perceive physical pain. From birth, they are unable to sense pain. Patients with congenital insensitivity to pain with anhidrosis (CIPA) also have decreased or absent sweating and cannot feel temperature, in addition to lacking pain awareness. Lacking pain awareness impedes the body's ability to detect danger and is extremely dangerous since individuals cannot assess risks as easily. This condition often leads to recurrent injuries such as bruising, broken bones, infections, and other health issues. For example, a person with congenital analgesia may bite their tongue, lips, or fingers in a seemingly normal way. Still, they are unaware of the severe damage caused, which can lead to infections. They are prone to additional injuries, including bruises, fractures, and cuts, which can escalate into more complications or even amputations when left untreated.
What Are The Causes of Congenital Analgesia?
Congenital analgesia is caused by genetic mutations in genes responsible for developing and functioning nociceptors, which are specialized nerve cells that receive and detect painful stimuli. Several genes are implicated, the most common ones being SCN9A and SCN11A. Inheritance patterns can vary in congenital analgesia; some forms of congenital analgesia only need one copy of the mutated gene to cause the condition, making it an autosomal dominant inheritance pattern. In comparison, some require both parents to carry the mutated gene, an autosomal recessive inheritance pattern.
Common Challenges of Congenital Analgesia
People with congenital analgesia can experience a multitude of challenges due to their inability to sense pain. Some common issues include:
Frequent injuries such as burns, cuts, and fractures.
Self-inflicted injuries, such as repetitive biting or chewing on their tongue, lips, and fingers.
Joint problems due to unrecognized injuries.
Delayed wound healing
Unnoticed infections or internal injuries that can become life-threatening.
Psychological or emotional impacts such as anxiety, hyperactivity, and difficulties with social interactions.
Caregivers must remain vigilant to identify injuries that might go unnoticed and prevent dangerous complications.
Diagnosis
Diagnosis is typically made through clinical evaluation, pain response tests, and genetic testing to identify mutations in SCN9A, SCN11A, or other related genes. Doctors look for a lack of withdrawal or other "normal" reactions in response to painful stimuli, especially in cases with unexplained and repetitive injuries. A thorough medical history and a physical examination are also essential to rule out other causes of pain insensitivity. Further confirmation may involve skin or nerve biopsies to examine nerve fibers or genetic testing to identify mutations. Sural nerve biopsy assesses the small myelinated nerve fibers that transmit pain signals, axonal flare tests assess the body's response to inflammation and nerve damage following a histamine injection, and skin biopsies evaluate the skin for the presence of nerve fibers.
Management and Treatment
Currently, there is no cure for congenital analgesia. Treatment encompasses injury prevention and management. Strategies include:
Educating patients and families about safety precautions.
Regular medical check-ups to monitor for undetected injuries or infections.
Use of protective gear to minimize injury risk.
Wound care and infection control.
Emotional Support.
Sources:
Assessed and Endorsed by the MedReport Medical Review Board
